Our published GWAS of MZL found two independent loci conferring risk, both in the HLA region of the genome[11], and a follow-up study reported that homozygosity at class I HLA-B and -C and class II HLA-DRB1 loci was associated with increased risk of MZL[41]. The gene discussed is HLA-DRB1; the disease is marginal zone lymphoma.